VECTIVBIO HLDG AG's ticker is VECT and the CUSIP is H9060V101. A total of 18 filers reported holding VECTIVBIO HLDG AG in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,866,721 | +1756.6% | 525,591 | +836.5% | 0.00% | – |
| Q1 2023 | $477,582 | -78.3% | 56,120 | -77.9% | 0.00% | -100.0% |
| Q4 2022 | $2,201,114 | +41.0% | 253,877 | -2.4% | 0.00% | 0.0% |
| Q3 2022 | $1,561,000 | +11.0% | 260,167 | -0.1% | 0.00% | 0.0% |
| Q2 2022 | $1,406,000 | +13.8% | 260,353 | -0.8% | 0.00% | – |
| Q1 2022 | $1,236,000 | -3.6% | 262,401 | +0.5% | 0.00% | – |
| Q4 2021 | $1,282,000 | -36.3% | 261,149 | +0.2% | 0.00% | -100.0% |
| Q3 2021 | $2,014,000 | -33.2% | 260,498 | +0.8% | 0.00% | 0.0% |
| Q2 2021 | $3,014,000 | – | 258,464 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,084,310 | $14,527,000 | 6.18% |
| Novo Holdings A/S | 3,380,402 | $15,922,000 | 0.84% |
| Cormorant Asset Management, LP | 2,078,485 | $9,790,000 | 0.75% |
| Orbimed Advisors | 5,330,704 | $25,108,000 | 0.41% |
| Bpifrance SA | 2,806,217 | $13,217,000 | 0.37% |
| Eventide Asset Management | 2,339,044 | $10,994,000 | 0.17% |
| Tekla Capital Management LLC | 756,502 | $3,556,000 | 0.12% |
| Canaan Partners XI LLC | 37,051 | $175,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 393,365 | $1,849,000 | 0.02% |
| Citadel Advisors | 2,722,646 | $12,797,000 | 0.00% |